Stifel Financial
RVNC

Stifel Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History

Stifel Financial’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-66,325
Closed -$170K – 3476
2024
Q2 		$170K Sell
66,325
-833
-1% -$2.85K ﹤0.01% 3138
2024
Q1 		$330K Buy
67,158
+48,211
+254% +$285K ﹤0.01% 2858
2023
Q4 		$167K Buy
18,947
+3,991
+27% +$32.7K ﹤0.01% 3090
2023
Q3 		$172K Buy
14,956
+700
+5% +$13.5K ﹤0.01% 3024
2023
Q2 		$361K Sell
14,256
-660
-4% -$20.6K ﹤0.01% 2726
2023
Q1 		$480K Sell
14,916
-2,036
-12% -$63.5K ﹤0.01% 2534
2022
Q4 		$313K Sell
16,952
-4,750
-22% -$109K ﹤0.01% 2734
2022
Q3 		$586K Buy
21,702
+4,941
+29% +$100K ﹤0.01% 2340
2022
Q2 		$232K Buy
+16,761
New +$258K ﹤0.01% 2896
2021
Q4 		– Sell
-15,847
Closed -$442K – 3489
2021
Q3 		$442K Buy
15,847
+3,667
+30% +$105K ﹤0.01% 2647
2021
Q2 		$362K Buy
12,180
+84
+0.7% +$2.42K ﹤0.01% 2772
2021
Q1 		$338K Sell
12,096
-1,781
-13% -$49.3K ﹤0.01% 2717
2020
Q4 		$393K Buy
13,877
+2,886
+26% +$74.8K ﹤0.01% 2460
2020
Q3 		$276K Sell
10,991
-2,731
-20% -$71.6K ﹤0.01% 2457
2020
Q2 		$335K Buy
13,722
+102
+0.7% +$2.01K ﹤0.01% 2283
2020
Q1 		$204K Sell
13,620
-5,841
-30% -$121K ﹤0.01% 2432
2019
Q4 		$319K Sell
19,461
-4,296
-18% -$66.6K ﹤0.01% 2502
2019
Q3 		$312K Buy
23,757
+1,953
+9% +$23.9K ﹤0.01% 2425
2019
Q2 		$286K Sell
21,804
-6,117
-22% -$77.1K ﹤0.01% 2529
2019
Q1 		$438K Buy
+27,921
New +$484K ﹤0.01% 2142

Other funds holding RVNC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Stifel Financial's RVNC Position: Q3 2024 in Review

Stifel Financial sold out of Revance Therapeutics, Inc. (RVNC) in Q3 2024, closing a stake of 66,325 shares — an estimated $170K sold.

Stifel Financial first reported a position in RVNC in Q1 2019 and held it in 20 quarters. The position peaked at $586K in Q3 2022. 201 funds tracked by Wall St. Rank hold RVNC as of Q3 2024.

  • Stifel Financial reported no remaining Revance Therapeutics, Inc. position as of Q3 2024 after selling out during the quarter.
  • Stifel Financial sold 66,325 Revance Therapeutics, Inc. shares in Q3 2024, an estimated $170K.
  • Stifel Financial first reported a position in Revance Therapeutics, Inc. in Q1 2019 and held it in 20 quarters.
  • Stifel Financial's Revance Therapeutics, Inc. position peaked at $586K in Q3 2022.
  • 201 funds tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q3 2024.

Based on Stifel Financial's 13F filing for Q3 2024, filed 14 Nov 2024.